Author: BusinessWire

Lead Tri-specific T cell Activating Construct (TriTAC) candidate,
HPN424, continues to advance in a Phase 1 clinical trial for the
treatment of prostate cancer

Initial public offering, successfull…

Conference Call Today at 4:30 p.m. Eastern Time

WATERTOWN, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24TTPH&src=ctag" target="_blank"gt;$TTPHlt;/agt; lt;a href="https://twitter.com/hasht…

HOUSTON–(BUSINESS WIRE)–Bio-Path Holdings, Inc. (Nasdaq: BPTH) (Bio-Path), a biotechnology
company leveraging its proprietary DNAbilize® antisense RNAi
nanoparticle technology to develop a portfolio of targeted nucleic acid
cance…

Both technologies address unmet needs for patients with celiac disease

NEWPORT BEACH, Calif.–(BUSINESS WIRE)–ImmunogenX is pleased to announce the initiation of a Phase 2 clinical
trial (named Celiac Shield™), sponsored by the Na…

New Front-Line Data Presented at Multidisciplinary Thoracic
Cancers Symposium

BOULDER, Colo. & SAN DIEGO–(BUSINESS WIRE)–Biodesix®
today presented new data demonstrating that the VeriStrat®
test is predictive of out…

DUBLIN–(BUSINESS WIRE)–The “Erectile
Dysfunction Drugs Market: Global Industry Analysis, Trends, Market Size,
and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
offering.

The report predic…

This session will feature video segments about a family dealing with
the heartbreak of opioid addiction

CRANBURY, N.J.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DIP2019?src=hash" target="_blank"gt…

DUBLIN–(BUSINESS WIRE)–The “Diabetes
Care Intelligence Center 2012-2023” report has been added to ResearchAndMarkets.com’s
offering.

The Diabetes Care Intelligence Center (IC) is a global
intelligence database on …

NEWTON, Mass.–(BUSINESS WIRE)–Cheetah Medical, a Massachusetts-based leader in non-invasive fluid
management, today announced it has concluded enrollment for the Fluid
Responsiveness Evaluation in Sepsis-associated Hypotension (FRESH) t…